
January 8, 2024
RegMed Investors’ (RMi) pre-open: let the music of JPM Healthcare conference begin
January 8, 2024
RegMed Investors (RMi) Research Note: Solid Biosciences (SLDB) Announces $109 Million Private Placement
January 5, 2024
RegMed Investors (RMi) Closing Bell: liquefying the sector from the pre-open thesis
January 5, 2024
RegMed Investors’ (RMi) pre-open: expectation versus actual,
January 5, 2024
RegMed Investors (RMi) Research Note: Voyager Therapeutics (VYGR) prices 7.77 M share public offering at $9.00 per share
January 4, 2024
RegMed Investors (RMi) Closing Bell: sector turnaround day as some value returns
January 4, 2024
RegMed Investors’ (RMi) pre-open: which go up, who go down and then the reverse
January 3, 2024
RegMed Investors (RMi) Closing Bell: not feelin’ the love as algorithmic “instructions carry-out a specific order to perform a particular task”
January 3, 2024
RegMed Investors’ (RMi) pre-open: value perceived is not always confidence achieved
January 2, 2024
RegMed Investors (RMi) Closing Bell: market trips, licensing news juices the cell and gene therapy sector for a while in session
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors